Persistent endothelial dysfunction after glycaemic improvement: intervention timing and functional outcomes
Endothelial dysfunction can persist after glycaemic improvement, but the evidence for its reversal depends on when treatment starts and which outcome is measured. This targeted narrative review compares experimental glucose-withdrawal studies, human vascular investigations and clinical follow-up reports by exposure, intervention timing, cellular source and endpoint. Persistent abnormalities involve inflammatory chromatin regulation, redox signalling, mitochondrial maintenance, DNA methylation and endothelial repair. Interventions started during glucose lowering improved arterial relaxation or reduced microvascular leakage in experimental models. Mitochondrial interventions improved organelle measurements without establishing vascular functional recovery. Evidence for treatment after a documented period of persistence is limited: selected studies measured repair behaviour, inflammatory responses or organ function, with unresolved timing or pretreatment-state limitations. These findings do not establish sustained reversal of an established endothelial deficit. Human studies report improvement in selected forearm and skin responses and acute glucagon-like peptide-1 responsiveness, alongside studies with no detectable improvement in flow-mediated dilation. A qualitative examination that sets aside reports with uncertain schedules or incomplete assessment retains support for endpoint-specific modifiability during glucose lowering; the evidence for delayed reversal remains limited. Endocrine, mitochondrial and vascular observations from separate settings do not establish a complete causal pathway. Sex representation and donor replication further constrain generalisation. Recovery studies should document the pretreatment deficit under stable, improved glycaemia, pair molecular and vascular measurements, and assess benefit during continued treatment and after withdrawal. Effects on clinical events require separate evaluation.
Authors
- Yihong Wei (ORCID: https://orcid.org/0009-0003-3114-9887)
- X Y Feng (ORCID: https://orcid.org/0000-0001-8826-6310)
- Si-Yu Qiao
- Lin Shen (ORCID: https://orcid.org/0000-0001-9735-120X)
- Duan Zhou
- Yuan-ye Gu
- Yan-yun Ma
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fendo.2026.2030665
- Primary Topic
- Nitric Oxide and Endothelin Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- National Key Research and Development Program of China